Exogems SA (Seed)
Funding Details
- Awarder
- Inbox
- Date Award
- August 29, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $540,000
Company Info
- Traction
- Successful completion of a CHF 500K fundraising round from business angels.
- Founders
- Dr. Bisognano Carmelo
- Company Description
- Exogems is a Swiss biotech company developing therapeutic exosomes derived from microfragmented adipose tissue to treat inflammation, infection, and cancer. The company's innovative approach harnesses the unique properties of exosomes to create targeted, effective, and safe treatments for various diseases.
- Market
- Therapeutic Exosomes
- Location
- Lausanne, Switzerland